Nan Zhang

Nan Zhang

Auto-generated profile, based on publicly available information

Nan Zhang

Central Laboratory, The First Hospital of Hebei Medical University, Shijiazhuang 050031, People’s Republic of China

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
NZNan Zhang
Nan Zhang
XZXiangjian Zhang
Xiangjian Zhang
XLXiaoxia Liu
Xiaoxia Liu
HWHong Wang
Hong Wang
JXJing Xue
Jing Xue
XWXiaolu Wang
Xiaolu Wang
The most effective way to contain cerebral ischemic injury is reperfusion; however, reperfusion itself may result in tissue injury, for which inflammatory damage is one of the main causative factors. NALP3 inflammasome is a multiprotein complex. It consists of NALP3, ASC, and caspase-1, whose function is to switch on the inflammatory process. Chrysophanol is an extract from plants of Rheum genus and it possesses many pharmacological effects including its anti-inflammation activity. In this study, the effects of chrysophanol in cerebral ischemia/reperfusion and the potential mechanisms were investigated. Male CD1 mice were subject to transient middle cerebral artery occlusion (tMCAO). The NALP3 inflammasome activation status and its dynamic expression during the natural inflammatory response induced by tMCAO were first profiled. The neuroprotective effects of chrysophanol were then assessed and the potential mechanisms mediating the observed neuroprotection were then explored. Physical parameters including neurological deficit, infarct size, brain edema, and BBB permeability were measured at 24 h after tMCAO. Confocal microscopy, Western blotting, immunohistochemistry, and qRT-PCR techniques were utilized to analyze the expression of NALP3 inflammasome and IL-1β. Our results indicated that the brain tissue damage during cerebral ischemia/reperfusion is accompanied by NALP3 inflammasome activation. Chrysophanol could inhibit the activation of NALP3 inflammasome and protect cerebral ischemic stroke.

1 May 2014 in Neuroscience
Verified
Journal Article
Closed access
XLX. Liu
X. Liu
XZXiangjian Zhang
Xiangjian Zhang
JZJ. Zhang
J. Zhang
NKN. Kang
N. Kang
NZN. Zhang
N. Zhang
XWX. Wang
X. Wang

1 April 2016 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
JXJing Xue
Jing Xue
XZXiangjian Zhang
Xiangjian Zhang
CZCong Zhang
Cong Zhang
NKNing Kang
Ning Kang
XLXiaoxia Liu
Xiaoxia Liu
XWXiaolu Wang
Xiaolu Wang

1 February 2017 in Neuropharmacology
Verified
Journal Article
Closed access
NZNan Zhang
Nan Zhang
SYShengchang Yang
Shengchang Yang
CWChang Wang
Chang Wang
JZJianghua Zhang
Jianghua Zhang
LHLifang Huo
Lifang Huo
WZWei ZHANG
Wei ZHANG

1 March 2018 in Anesthesiology
Verified
Journal Article
Open access
PDF file
YXYuan Xing
Yuan Xing
NZNan Zhang
Nan Zhang
WZWei Zhang
Wei Zhang
LRLei-Ming Ren
Lei-Ming Ren
Background: Bupivacaine induces central neurotoxicity at lower blood concentrations than cardiovascular toxicity. However, central sensitivity to bupivacaine is poorly understood. The toxicity mechanism might be related to glutamate-induced excitotoxicity in hippocampal cells.Methods: The intracellular free Ca2+concentration ([Ca2+]i), mitochondrial membrane potential, and reactive oxygen species generation were measured by fluorescence and two-photon laser scanning microscopy in fetal rat hippocampal neurons and astrocytes.Results: In astrocyte/neuron cocultures, 300 μM bupivacaine inhibited glutamate-induced increases in [Ca2+]iin astrocytes by 40% (P< 0.0001; n = 20) but significantly potentiated glutamate-induced increases in [Ca2+]iin neurons by 102% (P= 0.0007; n = 10). Ropivacaine produced concentration-dependent effects similar to bupivacaine (0.3 to 300 μM). Tetrodotoxin did not mimic bupivacaine’s effects. In pure cell cultures, bupivacaine did not affect glutamate-induced increases in [Ca2+]iin neurons but did inhibit increased [Ca2+]iin astrocytes. Moreover, bupivacaine produced a 61% decrease in the mitochondrial membrane potential (n = 20) and a 130% increase in reactive oxygen species generation (n = 15) in astrocytes. Cyclosporin A treatment suppressed bupivacaine’s effects on [Ca2+]i, mitochondrial membrane potential, and reactive oxygen species generation. When astrocyte/neuron cocultures were incubated with 500 μM dihydrokainic acid (a specific glutamate transporter–1 inhibitor), bupivacaine did not potentiate glutamate-induced increases in [Ca2+]iin neurons but still inhibited glutamate-induced increases in [Ca2+]iin astrocytes.Conclusions: In primary rat hippocampal astrocyte and neuron cocultures, clinically relevant concentrations of bupivacaine selectively impair astrocytic mitochondrial function, thereby suppressing glutamate uptake, which indirectly potentiates glutamate-induced increases in [Ca2+]iin neurons.

3 September 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
NZNan Zhang
Nan Zhang
RZRui Zhang
Rui Zhang
LJLei Jiang
Lei Jiang
ZGZhaoyu Gao
Zhaoyu Gao
WXWenzhen Xia
Wenzhen Xia
SXShunjiang Xu
Shunjiang Xu
Epidemiological studies have revealed an inverse relationship between the incidence of Alzheimer’s disease (AD) and various cancers, including colorectal cancer (CRC). We aimed to determine whether the incidence of CRC is reduced in AD-like mice and whether gut microbiota confers resistance to tumorigenesis through inducing inflammatory tolerance using 16S ribosomal RNA gene sequencing and fecal microbiota transplantation (FMT). AD-like mice experienced a significantly decreased incidence of CRC tumorigenesis induced by azoxymethane–dextran sodium sulfate as evidenced by suppressed intestinal inflammation compared with control mice. However, FMT from age-matched control mice reversed the inhibitory effects on the tumorigenesis of CRC and inflammatory response in AD-like mice. The key bacterial genera in gut microbiota, including Prevotella , were increased in both the AD-like mice and in patients with amnestic mild cognitive impairment (aMCI) but were decreased in patients with CRC. Pretreatment with low-dose Prevotella -derived lipopolysaccharides (LPS) induced inflammatory tolerance both in vivo and in vitro and inhibited CRC tumorigenesis in mice. Imbalanced gut microbiota increased intestinal barrier permeability, which facilitated LPS absorption from the gut into the blood, causing cognitive decline in AD-like mice and patients with aMCI. These data reveal that intestinal Prevotella -derived LPS exerts a resistant effect to CRC tumorigenesis via inducing inflammatory tolerance in the presence of AD. These findings provide biological evidence demonstrating the inverse relationship between the incidence of AD and CRC.